SUBSCRIBE
SUBSCRIBE
News   Drug Development

AstraZeneca PLC’s Crestor Fails in New Heart-Failure Study

September 2, 2008 | 
1 min read
MUNICH, Aug 31 (Reuters) - AstraZeneca Plc's cholesterol drug Crestor has failed in a second clinical trial for heart failure, suggesting such statin medicines don't improve survival in patients with the chronic condition.
Clinical research Postmarket research
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.
Obesity
Zealand Freezes Mid-Stage Obesity Asset to Focus on More Differentiated Drugs
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage image sketch of tired girl sleeping home nightmare monster in room isolated on drawing background.
Neuroscience
Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Altimmune Poised for $1B+ Opportunity as MASH Drug Aces Phase IIb
November 12, 2025
 · 
2 min read
 · 
Tristan Manalac